ERBB2 and neoplasm: As part of a research protocol to uniformly perform panel-based testing, the initial colonoscopy biopsy was tested for MSI by NGS, revealing MSS status.2 In addition to revealing low TMB (1 mutation/megabase), the panel also identified ERBB2 amplification (for a complete molecular profile of the tumor, see the Data Supplement).